BioSpace News Archive

Biotech Beach

Rakuten Medical Presented at the 41st Annual J.P. Morgan Healthcare Conference on the Progress of its Pipeline including its Newly Added Antibody-Dye Conjugate RM-0256, Commercial Growth in Japan, and Important Milestones for the Next Few Years

Mickey Mikitani, Co-CEO of Rakuten Medical, Inc. gave a presentation to investors from around the world at the 41st Annual J.P. Morgan Healthcare Conference (JPM2023) on January 10, 2023, in San Francisco, California, U.S.

January 30, 2023
·
8 min read
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology

Oricell Therapeutics Co., Ltd (Oricell) today announced publication of data from a clinical study evaluating the efficacy of OriCAR-017, an autologous GPRC5D-directed CAR-T cell therapy, in the treatment of relapsed/refractory multiple myeloma (RRMM) in an article entitled “Phase 1 Open-Label Single-Centre Single Arm Study of GPRC5D CAR T Cells(OriCAR-017) in Patients with Relapsed/Refractory Multiple Myeloma (POLARIS)” in The Lancet Haematology (2022 impact factor: 30.153).

January 30, 2023
·
6 min read
Drug Development

Qurient Announces Dosing of First Patient in Q702 in Combination with KEYTRUDA® in a Phase 1b/2 Clinical Study for the Treatment of Patients with Solid Tumors

Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the first patient has been dosed in the Phase 1b/2 clinical study of Q702 in combination with KEYTRUDA® (pembrolizumab).

January 30, 2023
·
2 min read
Business

SQI Diagnostics Reports Fourth Quarter and Fiscal 2022 Results

SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2022.

January 30, 2023
·
6 min read